Sai Life Sciences Limited

NSE: SAILIFE

28

total announcements

SAILIFE.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 16 Oct 2026

Market Cap

₹29,634 Cr

P/E (TTM)

82.4

P/E (Forward)

55.7

EPS (TTM)

₹16.93

52W Low

₹783.85

52W High

₹1,697.00

Dividend Yield

0.00%

Price / Book

11.9

Debt / Equity

11.6

Revenue (TTM)

₹2,250 Cr

Gross Margin

74.46%

Operating Margin

18.41%

NSEPress Release▲ PositiveResults6 Aug 2026

Sai Life Sciences Limited

Press Release

Sai Life Sciences Limited has reported strong financial results for the first quarter ended June 30, 2026, with revenue up 12% year-on-year and net profit up 22% year-on-year.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults6 Aug 2026

Sai Life Sciences Limited

Outcome of Board Meeting

Sai Life Sciences Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations at Rs. 5,467.29 million and profit for the period at Rs. 713.39 million.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026

Sai Life Sciences Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Sai Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investors meet to be held on 13 August 2026 & 14 August 2026 at Singapore.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults30 Jul 2026

Sai Life Sciences Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Sai Life Sciences Limited has informed the Exchange about the schedule of an earnings conference call to discuss the Un Audited Financial Results of the Company for the Quarter ended 30 June 2026.

Read more →📎 1 attachment
NSEESOP/ESOS/ESPSESG10 Jul 2026

Sai Life Sciences Limited

ESOP/ESOS/ESPS

Sai Life Sciences Limited has informed the Exchange regarding the allotment of 8,900 shares under the Employees Stock Option Plan 2008 (ESOP 2008).

Read more →📎 1 attachment
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory7 Jul 2026

Sai Life Sciences Limited

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sai Life Sciences Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, regarding the details of securities dematerialized/rematerialized during the period.

Read more →📎 1 attachment
NSETrading Window25 Jun 2026

Sai Life Sciences Limited

Trading Window

Sai Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
NSEAllotment of SecuritiesFundraise22 Jun 2026

Sai Life Sciences Limited

Allotment of Securities

Sai Life Sciences Limited has allotted 170,501 fully paid-up equity shares of Re. 1/- each to employees who exercised options granted under its ESOP 2008 and MESOP 2018 schemes. This allotment, approved on June 22, 2026, increases the total issued shares to 21,22,86,016. The shares were issued at varying exercise prices of Rs. 188.90, Rs. 23.30, and Rs. 127.30, resulting in a minor capital inflow for the company.

Read more →📎 1 attachment
← PreviousPage 2 of 2